Centennial Bank’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-10
Closed -$191 327
2024
Q3
$191 Sell
10
-18
-64% -$373 ﹤0.01% 320
2024
Q2
$558 Buy
28
+17
+155% +$338 ﹤0.01% 326
2024
Q1
$188 Hold
11
﹤0.01% 329
2023
Q4
$144 Sell
11
-15
-58% -$204 ﹤0.01% 329
2023
Q3
$435 Sell
26
-622
-96% -$13K ﹤0.01% 314
2023
Q2
$13.5K Sell
648
-1
-0.2% -$22 0.01% 252
2023
Q1
$15.2K Sell
649
-130
-17% -$3.49K 0.01% 248
2022
Q4
$21.8K Buy
+779
New +$19.9K 0.01% 254

Other funds holding OGN

Centennial Bank's OGN Position: Q4 2024 in Review

Centennial Bank sold out of Organon & Co (OGN) in Q4 2024, closing a stake of 10 shares — an estimated $191 sold.

Centennial Bank first reported a position in OGN in Q4 2022 and held it in 8 quarters. The position peaked at $21.8K in Q4 2022. 740 funds tracked by Wall St. Rank hold OGN as of Q4 2024.

  • Centennial Bank reported no remaining Organon & Co position as of Q4 2024 after selling out during the quarter.
  • Centennial Bank sold 10 Organon & Co shares in Q4 2024, an estimated $191.
  • Centennial Bank first reported a position in Organon & Co in Q4 2022 and held it in 8 quarters.
  • Centennial Bank's Organon & Co position peaked at $21.8K in Q4 2022.
  • 740 funds tracked by Wall St. Rank held Organon & Co as of Q4 2024.

Based on Centennial Bank's 13F filing for Q4 2024, filed 6 Feb 2025.